In a letter to shareholders, RegeneRx provided a pipeline update for investors Monday morning, outlining plans to potentially move forward with a new asset in light of development delays.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,